Can coenzyme Q10 improve clinical and molecular parameters in fibromyalgia?

Antioxidants and Redox Signaling

Volumn 19, Issue 12, 2013, Pages 1356-1361

  Cordero, Mario D ^a   Alcocer Gómez, Elísabet ^a   De Miguel, Manuel ^a   Culic, Ognjen ^b   Carrión, Angel M ^c   Alvarez Suarez, José Miguel ^d   Bullón, Pedro ^e   Battino, Maurizio ^d   Fernández Rodríguez, Ana ^a   Sánchez Alcazar, José Antonio ^f  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e UNIVERSITY OF SEVILLE   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLACEBO; TRANSCRIPTION FACTOR NRF1; UBIDECARENONE; ADENYLATE KINASE; SUPEROXIDE DISMUTASE; UBIQUINONE; DRUG DERIVATIVE;

ADULT; ANALGESIC ACTIVITY; BIOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATIGUE; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID PEROXIDATION; MITOCHONDRION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; ANALOGS AND DERIVATIVES; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MITOCHONDRIAL DYNAMICS; TREATMENT OUTCOME; ARTICLE; CONTROLLED CLINICAL TRIAL;

ADENYLATE KINASE; ADULT; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; GENE EXPRESSION; HUMANS; MIDDLE AGED; MITOCHONDRIAL TURNOVER; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME; UBIQUINONE;

EID: 84884913935     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5260     Document Type: Review

References (9)

1. Bazzichi L, Giannaccini G, Betti L, Fabbrini L, Schmid L, Palego L, Giacomelli C, Rossi A, Giusti L, De Feo F, Giuliano T, Mascia G, Bombardieri S, and Lucacchini A. ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia. Clin Biochem 41: 1084-1090, 2008.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgramquantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
3. Colombo SL and Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421: 163-169, 2009.
4. Cordero MD, de Miguel M, Carmona-López I, Bonal P, Campa F, and Moreno-Fernández AM. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett 31: 169-173, 2010.
5. Cordero MD, D?́az-Parrado E, Carrión AM, Alfonsi S, Sánchez-Alcazar JA, Bullón P, Battino M, and de Miguel M. Is inflammation a mitochondrial dysfunction-dependent event in Fibromyalgia? Antioxid Redox Signal 18: 800-807, 2012.
6. Hardie DG, Ross FA, and Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13: 251-262, 2012.
7. Lee SK, Lee JO, Kim JH, Kim N, You GY, Moon JW, Sha J, Kim SJ, Lee YW, Kang HJ, Park SH, and Kim HS. Coenzyme Q10 increases the fatty acid oxidation through AMPK-mediated PPARa induction in 3T3-L1 preadipocytes. Cell Signal 24: 2329-2336, 2012.
8. Lister RE. An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome. J Int Med Res 30: 195-199, 2002.
9. Tsai KL, Chen LH, Chiou SH, Chiou GY, Chen YC, Chou HY, Chen LK, Chen HY, Chiu TH, Tsai CS, Ou HC, and Kao CL. Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway. Mol Nutr Food Res 55: S227-S240, 2011.